Rockley Photonics Holdings LTD RKLY
We take great care to ensure that the data presented and summarized in this overview for Rockley Photonics Holdings Ltd is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in RKLY
Top Purchases
Top Sells
About RKLY
Rockley Photonics Holdings Limited develops and supplies silicon photonics in the United Kingdom and internationally. It offers a platform, which comprises photonic integrated circuits in silicon with integrated III-V devices; application-specific electronic integrated circuits; photonic and electronic co-packaging, which are supported by and coupled with biosensing algorithms, artificial intelligence, cloud analytics, firmware/software, system architecture, and hardware design. The company also provides a biosensing platform for consumer wellness, long-term health trend monitoring, patient monitoring, early disease detection, nutrition management, and treatment of certain chronic diseases. Rockley Photonics Holdings Limited was founded in 2013 and is headquartered in Altrincham, the United Kingdom.
Insider Transactions at RKLY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 11
2022
|
Andrew George Rickman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,655
-0.06%
|
$9,655
$1.48 P/Share
|
Aug 11
2022
|
Andrew George Rickman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,100
+0.13%
|
-
|
May 16
2022
|
William Huyett Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,333
+18.49%
|
-
|
May 16
2022
|
Pamela Puryear Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,333
+50.0%
|
-
|
May 16
2022
|
Brian J Blaser Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,333
+11.88%
|
-
|
May 16
2022
|
Michele Klein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,333
+50.0%
|
-
|
May 16
2022
|
Caroline Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,333
+50.0%
|
-
|
May 16
2022
|
Karim Karti Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,333
+18.97%
|
-
|
Mar 25
2022
|
Amit Nagra Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+19.4%
|
$0
$0.54 P/Share
|
Mar 18
2022
|
Brian J Blaser Director |
BUY
Open market or private purchase
|
Direct |
47,060
+68.14%
|
$188,240
$4.19 P/Share
|
Mar 15
2022
|
Andrew George Rickman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,301
-0.07%
|
$36,903
$3.9 P/Share
|
Mar 15
2022
|
Amit Nagra Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,098
-1.07%
|
$15,294
$3.9 P/Share
|
Mar 15
2022
|
Mahesh Karanth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,261
-4.52%
|
$24,783
$3.9 P/Share
|
Jan 27
2022
|
Amit Nagra Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
450,000
+48.22%
|
$0
$0.54 P/Share
|
Dec 16
2021
|
Andrew George Rickman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
574,713
+3.09%
|
-
|
Dec 13
2021
|
Mahesh Karanth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,434
+50.0%
|
-
|
Dec 13
2021
|
Amit Nagra Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,075
+50.0%
|
-
|
Nov 23
2021
|
William Huyett Director |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$150,000
$6.59 P/Share
|